260 related articles for article (PubMed ID: 27660204)
1. MC1568 Inhibits Thimerosal-Induced Apoptotic Cell Death by Preventing HDAC4 Up-Regulation in Neuronal Cells and in Rat Prefrontal Cortex.
Guida N; Laudati G; Mascolo L; Cuomo O; Anzilotti S; Sirabella R; Santopaolo M; Galgani M; Montuori P; Di Renzo G; Canzoniero LM; Formisano L
Toxicol Sci; 2016 Dec; 154(2):227-240. PubMed ID: 27660204
[TBL] [Abstract][Full Text] [Related]
2. HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage.
Formisano L; Laudati G; Guida N; Mascolo L; Serani A; Cuomo O; Cantile M; Boscia F; Molinaro P; Anzilotti S; Pizzorusso V; Di Renzo G; Pignataro G; Annunziato L
J Cereb Blood Flow Metab; 2020 Oct; 40(10):2081-2097. PubMed ID: 31696766
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 4 promotes ubiquitin-dependent proteasomal degradation of Sp3 in SH-SY5Y cells treated with di(2-ethylhexyl)phthalate (DEHP), determining neuronal death.
Guida N; Laudati G; Galgani M; Santopaolo M; Montuori P; Triassi M; Di Renzo G; Canzoniero LM; Formisano L
Toxicol Appl Pharmacol; 2014 Oct; 280(1):190-8. PubMed ID: 25068794
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.
Xiong C; Guan Y; Zhou X; Liu L; Zhuang MA; Zhang W; Zhang Y; Masucci MV; Bayliss G; Zhao TC; Zhuang S
FASEB J; 2019 Jul; 33(7):8249-8262. PubMed ID: 30951378
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells.
Colarossi L; Memeo L; Colarossi C; Aiello E; Iuppa A; Espina V; Liotta L; Mueller C
Proteomics Clin Appl; 2014 Dec; 8(11-12):924-31. PubMed ID: 25091122
[TBL] [Abstract][Full Text] [Related]
7. Class IIa histone deacetylases affect neuronal remodeling and functional outcome after stroke.
Kassis H; Shehadah A; Li C; Zhang Y; Cui Y; Roberts C; Sadry N; Liu X; Chopp M; Zhang ZG
Neurochem Int; 2016 Jun; 96():24-31. PubMed ID: 27103167
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
Kim GR; Cho SN; Kim HS; Yu SY; Choi SY; Ryu Y; Lin MQ; Jin L; Kee HJ; Jeong MH
J Hypertens; 2016 Nov; 34(11):2206-19. PubMed ID: 27512969
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
[TBL] [Abstract][Full Text] [Related]
10. Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease.
Mazzocchi M; Goulding SR; Morales-Prieto N; Foley T; Collins LM; Sullivan AM; O'Keeffe GW
Brain Behav Immun; 2022 May; 102():151-160. PubMed ID: 35217173
[TBL] [Abstract][Full Text] [Related]
11. MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3/REST complex on the synapsin-1 promoter.
Formisano L; Guida N; Laudati G; Mascolo L; Di Renzo G; Canzoniero LM
J Pharmacol Exp Ther; 2015 Feb; 352(2):236-43. PubMed ID: 25467131
[TBL] [Abstract][Full Text] [Related]
12. MC1568 Enhances Histone Acetylation During Oocyte Meiosis and Improves Development of Somatic Cell Nuclear Transfer Embryos in Pig.
Wang H; Cui W; Meng C; Zhang J; Li Y; Qian Y; Xing G; Zhao D; Cao S
Cell Reprogram; 2018 Feb; 20(1):55-65. PubMed ID: 29412739
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol treatment reduces the vulnerability of SH-SY5Y cells and cortical neurons overexpressing SOD1-G93A to Thimerosal toxicity through SIRT1/DREAM/PDYN pathway.
Laudati G; Mascolo L; Guida N; Sirabella R; Pizzorusso V; Bruzzaniti S; Serani A; Di Renzo G; Canzoniero LMT; Formisano L
Neurotoxicology; 2019 Mar; 71():6-15. PubMed ID: 30503815
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling.
Illi B; Dello Russo C; Colussi C; Rosati J; Pallaoro M; Spallotta F; Rotili D; Valente S; Ragone G; Martelli F; Biglioli P; Steinkuhler C; Gallinari P; Mai A; Capogrossi MC; Gaetano C
Circ Res; 2008 Jan; 102(1):51-8. PubMed ID: 17975112
[TBL] [Abstract][Full Text] [Related]
15. Specific activity of class II histone deacetylases in human breast cancer cells.
Duong V; Bret C; Altucci L; Mai A; Duraffourd C; Loubersac J; Harmand PO; Bonnet S; Valente S; Maudelonde T; Cavailles V; Boulle N
Mol Cancer Res; 2008 Dec; 6(12):1908-19. PubMed ID: 19074835
[TBL] [Abstract][Full Text] [Related]
16. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
17. MC1568 improves insulin secretion in islets from type 2 diabetes patients and rescues β-cell dysfunction caused by Hdac7 upregulation.
Daneshpajooh M; Eliasson L; Bacos K; Ling C
Acta Diabetol; 2018 Dec; 55(12):1231-1235. PubMed ID: 30088095
[TBL] [Abstract][Full Text] [Related]
18. Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29.
Mannaerts I; Eysackers N; Onyema OO; Van Beneden K; Valente S; Mai A; Odenthal M; van Grunsven LA
PLoS One; 2013; 8(1):e55786. PubMed ID: 23383282
[TBL] [Abstract][Full Text] [Related]
19. Class II histone deacetylases require P/Q-type Ca
Urbano FJ; Bisagno V; Mahaffey S; Lee SH; Garcia-Rill E
Sci Rep; 2018 Sep; 8(1):13156. PubMed ID: 30177751
[TBL] [Abstract][Full Text] [Related]
20. Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma.
Kikuchi S; Suzuki R; Ohguchi H; Yoshida Y; Lu D; Cottini F; Jakubikova J; Bianchi G; Harada T; Gorgun G; Tai YT; Richardson PG; Hideshima T; Anderson KC
Leukemia; 2015 Sep; 29(9):1918-27. PubMed ID: 25801913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
